The American Journal of Medicine
Volume 117, Issue 3 , Pages 158-162 , 1 August 2004

Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men

  • Elisabeth F.C van Rossum, MD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationRequests for reprints should be addressed to Elisabeth F. C. van Rossum, MD, Department of Internal Medicine, Room Ee 585 B, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
  • ,
  • Richard A Feelders, MD, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Annewieke W van den Beld, MD, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • André G Uitterlinden, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Joop A.M.J.L Janssen, MD, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Wietske Ester, MD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Albert O Brinkmann, PhD

      Affiliations

    • Department of Reproduction and Development (AB), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Diederick E Grobbee, PhD

      Affiliations

    • Julius Center (DG), University of Utrecht, Rotterdam, The Netherlands
  • ,
  • Frank H de Jong, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Huibert A.P Pols, MD, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Jan W Koper, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Steven W.J Lamberts, MD, PhD

      Affiliations

    • Department of Internal Medicine (EvR, RF, AvdB, AU, JJ, WE, FdJ, HP, JK, SL), Erasmus Medical Center, Rotterdam, The Netherlands

Received 17 June 2003 ,Revised 29 January 2004 ,Accepted 29 January 2004.

References 

  1. Baxter JD, Rousseau GG. Glucocorticoid hormone action (an overview). Monogr Endocrinol. 1979;12:1–24
  2. van Rossum EF, Koper JW, Huizenga NA, et al.  A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes. 2002;51:3128–3134
  3. Harris TB, Ferrucci L, Tracy RP, et al.  Associations of elevated interleukin 6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506–512
  4. Ridker PM, Cushman M, Stampfer MJ, et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  5. Ridker PM, Buring JE, Shih J, et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731–733
  6. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;144:537–547
  7. Thompson SG, Kienast J, Pyke SD, et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635–641
  8. Le JM, Vilcek J. Interleukin 6 (a multifunctional cytokine regulating immune reactions and the acute phase protein response). Lab Invest. 1989;61:588–602
  9. Gauldie J, Richards C, Northemann W, et al.  IFN beta 2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann N Y Acad Sci. 1989;557:46–58
  10. Biasucci LM, Vitelli A, Liuzzo G, et al.  Elevated levels of interleukin 6 in unstable angina. Circulation. 1996;94:874–877
  11. Torre-Amione G, Kapadia S, Benedict C, et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction (a report from the Studies of Left Ventricular Dysfunction (SOLVD)). J Am Coll Cardiol. 1996;27:1201–1206
  12. Gotfredsen A, Jensen J, Borg J, Christiansen C. Measurement of lean body mass and total body fat using dual photon absorptiometry. Metabolism. 1986;35:88–93
  13. Guralnik JM, Seeman TE, Tinetti ME, et al.  Validation and use of performance measures of functioning in a non-disabled older population (MacArthur studies of successful aging). Aging (Milano). 1994;6:410–419
  14. Pincus T, Summey JA, Soraci SA, et al.  Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346–1353
  15. Koper JW, Stolk RP, de Lange P, et al.  Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet. 1997;99:663–668
  16. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20:1057–1060
  17. Rattazzi M, Puato M, Faggin E, et al.  C-reactive protein and interleukin 6 in vascular disease (culprits or passive bystanders?). J Hypertens. 2003;21:1787–1803
  18. Frohlich M, Imhof A, Berg G, et al.  Association between C-reactive protein and features of the metabolic syndrome (a population-based study). Diabetes Care. 2000;23:1835–1839
  19. Hak AE, Stehouwer CD, Bots ML, et al.  Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999;19:1986–1991
  20. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects (associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?). Arterioscler Thromb Vasc Biol. 1999;19:972–978
  21. Visser M, Bouter LM, McQuillan GM, et al.  Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–2135
  22. Mohamed-Ali V, Goodrick S, Rawesh A, et al.  Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196–4200
  23. DeRijk R, Michelson D, Karp B, et al.  Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans (high sensitivity of TNF alpha and resistance of IL-6). J Clin Endocrinol Metab. 1997;82:2182–2191
  24. Rock CS, Coyle SM, Keogh CV, et al.  Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans. Surgery. 1992;112:467–474
  25. Snyers L, De Wit L, Content J. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci U S A. 1990;87:2838–2842
  26. Ouchi N, Kihara S, Funahashi T, et al.  Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671–674

 This research project was supported by a grant from NWO and Research Institute of Diseases in the Elderly.

PII: S0002-9343(04)00243-8

doi: 10.1016/j.amjmed.2004.01.027

The American Journal of Medicine
Volume 117, Issue 3 , Pages 158-162 , 1 August 2004